ABCG2 and cancer: Overexpression of the ABC transporters, ABCB1 and ABCG2, are two of the major mediators of MDR in cancer, and antagonists targeting ABCB1 and ABCG2 have undergone clinical Antagonists targeting ABCB1 and ABCG2 have been clinically evaluated; unfortunately, none have been clinically approved.